155 related articles for article (PubMed ID: 34289279)
1. Salt-and-Pepper Skin Changes in Systemic Sclerosis.
Colquhoun M; Penn H
N Engl J Med; 2021 Jul; 385(4):357. PubMed ID: 34289279
[No Abstract] [Full Text] [Related]
2. Rare cutaneous involvement as the first manifestation of systemic sclerosis.
Pinto AS; Teixeira F; Teixeira V
Rheumatology (Oxford); 2022 Feb; 61(2):878. PubMed ID: 33974071
[No Abstract] [Full Text] [Related]
3. Reticulate hyperpigmentation in systemic sclerosis: a case report and review of the literature.
Chuamanochan M; Haws AL; Pattanaprichakul P
J Med Case Rep; 2015 Sep; 9():219. PubMed ID: 26412076
[TBL] [Abstract][Full Text] [Related]
4. Is Hyperpigmentation in Systemic Sclerosis a Perivascular Dermal Tattoo?
Henrot P; Moisan F; Seneschal J; Taïeb A; Cario M; Truchetet ME
J Invest Dermatol; 2020 Nov; 140(11):2308-2312.e2. PubMed ID: 32234458
[No Abstract] [Full Text] [Related]
5. Salt-and-Pepper Skin Changes.
Giberson M; Brassard A
N Engl J Med; 2017 Jul; 377(2):173. PubMed ID: 28700851
[No Abstract] [Full Text] [Related]
6. Pigmented skin patches without scleroderma as a predominant clinical symptom revealing systemic sclerosis.
Darrigade AS; Vedie AL; Gauthier C; Cario-André M; Taieb A; Truchetet ME; Constans J; Seneschal J
Clin Exp Dermatol; 2016 Jun; 41(4):379-82. PubMed ID: 27171356
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.
Solanki KK; Hor C; Chang WSJ; Frampton C; White DHN
Int J Rheum Dis; 2017 Jun; 20(6):767-773. PubMed ID: 28261995
[TBL] [Abstract][Full Text] [Related]
8. Reticulate hyperpigmented scleroderma: a new pigmentary manifestation.
Ee HL; Tan SH
Clin Exp Dermatol; 2005 Mar; 30(2):131-3. PubMed ID: 15725237
[TBL] [Abstract][Full Text] [Related]
9. Postinflammatory hypopigmentation and hyperpigmentation.
Ruiz-Maldonado R; Orozco-Covarrubias ML
Semin Cutan Med Surg; 1997 Mar; 16(1):36-43. PubMed ID: 9125764
[TBL] [Abstract][Full Text] [Related]
10. Scar depigmentation in systemic sclerosis.
Ramam M; Dogra D
Acta Derm Venereol; 1997 Sep; 77(5):411-2. PubMed ID: 9298151
[No Abstract] [Full Text] [Related]
11. [Diagnosis and therapy for systemic sclerosis].
Umehara H; Tanaka M; Masaki Y; Fukushima T
Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2165-70. PubMed ID: 18044151
[No Abstract] [Full Text] [Related]
12. [Antibodies against topoisomerase I (Scl-70)--comparative studies on detection with recombinant protein antigens and natural enzyme].
Seelig HP; Schröter H; Ehrfeld H; Renz M
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):505-11. PubMed ID: 7856253
[No Abstract] [Full Text] [Related]
13. Correlation between the concentration of serum anti-topoisomerase I autoantibodies and histological and biochemical alterations in the skin of tight skin mice.
Hatakeyama A; Kasturi KN; Wolf I; Phelps RG; Bona CA
Cell Immunol; 1996 Jan; 167(1):135-40. PubMed ID: 8548837
[TBL] [Abstract][Full Text] [Related]
14. Reversible cutaneous hyperpigmentation and nails with white hair due to vitamin B12 deficiency.
Niiyama S; Mukai H
Eur J Dermatol; 2007; 17(6):551-2. PubMed ID: 17951150
[No Abstract] [Full Text] [Related]
15. Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients.
Leroy V; Henrot P; Barnetche T; Cario M; Darrigade AS; Manicki P; Doutre MS; Lazaro E; Constans J; Barcat D; Vernhes JP; Richez C; Taieb A; Truchetet ME; Seneschal J;
J Am Acad Dermatol; 2019 Feb; 80(2):478-484. PubMed ID: 30092330
[TBL] [Abstract][Full Text] [Related]
16. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
17. [Systemic sclerosis (scleroderma) without scleroderma].
Nadashkevych ON
Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
[TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid in a patient with systemic sclerosis (scleroderma).
Sherber NS; Wigley FM; Anhalt GJ
J Rheumatol; 2006 Oct; 33(10):2098. PubMed ID: 17014027
[No Abstract] [Full Text] [Related]
19. Antibodies to topoisomerase I in sera from patients with scleroderma.
Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129
[TBL] [Abstract][Full Text] [Related]
20. Polyneuropathy as initial manifestation of systemic sclerosis (scleroderma).
Knupp-Oliveira S; Cerinic MM
Scand J Rheumatol; 1999; 28(4):260-1. PubMed ID: 10503566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
